J. F. Delfraissy

636 total citations
16 papers, 369 citations indexed

About

J. F. Delfraissy is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, J. F. Delfraissy has authored 16 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 6 papers in Virology and 6 papers in Epidemiology. Recurrent topics in J. F. Delfraissy's work include HIV Research and Treatment (6 papers), HIV/AIDS drug development and treatment (4 papers) and HIV/AIDS Research and Interventions (3 papers). J. F. Delfraissy is often cited by papers focused on HIV Research and Treatment (6 papers), HIV/AIDS drug development and treatment (4 papers) and HIV/AIDS Research and Interventions (3 papers). J. F. Delfraissy collaborates with scholars based in France, Switzerland and United States. J. F. Delfraissy's co-authors include Cécile Goujard, Christine Wallon, Yassine Taoufik, Olivier Lambotte, Olivier Lambotte, Rami Kotb, Anne Dulioust, Anne‐Marie Taburet, Isabelle Cohen-Codar and Delphine Peretti and has published in prestigious journals such as Gastroenterology, European Journal of Immunology and Bone.

In The Last Decade

J. F. Delfraissy

15 papers receiving 364 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. F. Delfraissy France 8 248 187 110 71 68 16 369
E. A. Watson United States 6 257 1.0× 148 0.8× 85 0.8× 147 2.1× 14 0.2× 10 372
Katia Bourdic France 7 359 1.4× 142 0.8× 267 2.4× 83 1.2× 65 1.0× 9 484
Carmella vandeVen United States 6 64 0.3× 82 0.4× 94 0.9× 124 1.7× 18 0.3× 10 359
Barbara Schock United States 8 216 0.9× 177 0.9× 105 1.0× 82 1.2× 38 0.6× 9 318
Kenneth Lynn United States 8 236 1.0× 118 0.6× 181 1.6× 75 1.1× 35 0.5× 13 344
Judith Delmar United States 9 377 1.5× 239 1.3× 204 1.9× 101 1.4× 71 1.0× 10 533
Charin Thepthai Thailand 11 119 0.5× 142 0.8× 63 0.6× 139 2.0× 29 0.4× 25 331
Rocío Bellido Spain 9 123 0.5× 123 0.7× 110 1.0× 58 0.8× 26 0.4× 16 302
Kathleen Busman‐Sahay United States 13 139 0.6× 143 0.8× 145 1.3× 83 1.2× 47 0.7× 21 380
Chris A. R. Baker United States 13 214 0.9× 117 0.6× 240 2.2× 84 1.2× 22 0.3× 21 422

Countries citing papers authored by J. F. Delfraissy

Since Specialization
Citations

This map shows the geographic impact of J. F. Delfraissy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. F. Delfraissy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. F. Delfraissy more than expected).

Fields of papers citing papers by J. F. Delfraissy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. F. Delfraissy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. F. Delfraissy. The network helps show where J. F. Delfraissy may publish in the future.

Co-authorship network of co-authors of J. F. Delfraissy

This figure shows the co-authorship network connecting the top 25 collaborators of J. F. Delfraissy. A scholar is included among the top collaborators of J. F. Delfraissy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. F. Delfraissy. J. F. Delfraissy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Delfraissy, J. F.. (2023). La recherche française face aux maladies infectieuses émergentes : de REACTing à l’ANRS- maladies infectieuses émergentes. Bulletin de l Académie Nationale de Médecine. 207(3). 287–294.
2.
Briot, Karine, S. Kolta, Philippe Flandre, et al.. (2011). Prospective one-year bone loss in treatment-naïve HIV+ men and women on single or multiple drug HIV therapies. Bone. 48(5). 1133–1139. 21 indexed citations
3.
Avettand-Fènoël, Véronique, Philippe Flandre, Marie‐Laure Chaix, et al.. (2010). Impact of 48 week lopinavir/ritonavir monotherapy on blood cell-associated HIV-1-DNA in the MONARK trial. Journal of Antimicrobial Chemotherapy. 65(5). 1005–1007. 16 indexed citations
4.
Bulifon, Sophie, V. Tsatsaris, François Goffinet, et al.. (2010). Pandémie grippale A/H1N1v, grossesse et vaccination. Médecine et Maladies Infectieuses. 40(12). 696–702. 3 indexed citations
5.
Bahnini, Amine, et al.. (2007). Isolement d'Actinomyces odontolyticus au cours d'une infection de prothèse aortique avec fistule duodénoparaprothétique. La Revue de Médecine Interne. 28(6). 412–415. 5 indexed citations
6.
Lambotte, Olivier & J. F. Delfraissy. (2006). Les « HIV controllers » : un groupe homogène de patients infectés par le VIH avec un contrôle spontané de la réplication virale. Pathologie Biologie. 54(10). 566–571. 5 indexed citations
7.
Boufassa, Faroudy, Isabelle Cartier, Thierry Lazure, et al.. (2006). Facteurs de risque d’acquisition de lésions du col utérin dans une population de femmes infectées par le VIH. Journal de gynécologie, obstétrique et biologie de la reproduction. Supplément. 35(5). 490–496. 1 indexed citations
8.
Kotb, Rami, Isabelle Vincent, Anne Dulioust, et al.. (2006). Life‐threatening interaction between antiretroviral therapy and vinblastine in HIV‐associated multicentric Castleman's disease. European Journal Of Haematology. 76(3). 269–271. 26 indexed citations
9.
Lambotte, Olivier, et al.. (2000). Detection of Infectious HIV in Circulating Monocytes From Patients on Prolonged Highly Active Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 23(2). 114–119. 173 indexed citations
10.
Lambotte, Olivier, et al.. (2000). Detection of Infectious HIV in Circulating Monocytes From Patients on Prolonged Highly Active Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 23(2). 114–119. 54 indexed citations
11.
Lien, Truong Xuan, Phạm Văn Hưng, W Lowenstein, et al.. (1999). Clinical and biological characteristics of human immunodeficiency virus-infected and uninfected intravascular drug users in Ho Chi Minh City, Vietnam.. American Journal of Tropical Medicine and Hygiene. 61(3). 420–424. 22 indexed citations
12.
Labétoulle, Marc, Cécile Goujard, E Frau, et al.. (1998). [Incidence and evaluation of viral retinitis in patients infected with the HIV virus and treated with HIV protease inhibitors].. PubMed. 21(8). 567–76. 2 indexed citations
13.
Chérìn, P., J. F. Delfraissy, O Blétry, J Dormont, & P Godeau. (1991). [Pulmonary arterial hypertension and systemic diseases].. PubMed. 58(5). 387–94. 5 indexed citations
14.
Socié, Gèrard, et al.. (1988). [Therapeutic problems in 2 patients with Hodgkin's disease and HIV 1 positive serology].. PubMed. 75(2). 229–32. 2 indexed citations
15.
Dugas, Bernard, et al.. (1986). Early events in human B cell activation: metabolic pathways vary according to the first signal used. European Journal of Immunology. 16(12). 1609–1614. 18 indexed citations
16.
Delfraissy, J. F., et al.. (1983). Brucellosis hepatic abcesses and pregnancy. Gastroenterology. 84(6). 1643–1643. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026